Our findings are also consistent with the observation of increased expression of Gal-1 in aggressive and metastatic oligodendroglioma [51], aggressive B16 melanoma [44], and Kaposi’s sarcoma [43]. The gene discussed is LGALS1; the disease is melanoma.